[Revascularization in Stable Ischemic Heart Disease: Whether to Change the Approach?]

L L Bershtein1, N O Katamadze1, A E Golovina1

  • 1North-Western State Medical University named after I.I. Mechnikov, St.-Petersburg, Russia.

Kardiologiia
|March 16, 2017
PubMed

Insights

Current guidelines for stable ischemic heart disease (IHD) recommend coronary revascularization, but evidence is outdated. New trials suggest optimal medical therapy (OMT) alone may suffice, necessitating further research.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Current guidelines for stable ischemic heart disease (IHD) recommend coronary revascularization based on symptoms, anatomy, and stress test results.
  • However, the evidence supporting these recommendations stems from older studies with different medical therapies and revascularization techniques.
  • Many conclusions are derived from observational studies and subanalyses, limiting their methodological reliability.

Purpose of the Study:

  • To critically analyze the evidence base for current coronary revascularization guidelines in stable IHD.
  • To review contemporary optimal medical therapy (OMT) components for stable IHD.
  • To discuss the necessity of large-scale randomized clinical trials comparing OMT versus OMT plus revascularization.

Main Methods:

  • Systematic review of existing literature and guidelines on stable IHD.
  • Analysis of data from historical and recent clinical trials.
  • Evaluation of contemporary OMT strategies.

Main Results:

  • Evidence supporting current revascularization guidelines is largely based on outdated data and methodologically limited studies.
  • Recent trials show conflicting results compared to older studies.
  • Contradictory opinions exist within the cardiology community regarding revascularization indications.

Conclusions:

  • The evidence base for current stable IHD revascularization guidelines requires re-evaluation due to outdated data and methodological limitations.
  • There is a pressing need for large-scale randomized clinical trials to compare OMT with OMT plus revascularization in stable IHD patients.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
354
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358